Want to see TSE:BBM full AI Analyst Report?
BBM Stock Chart & Stats
C$0.02
C$0.00(0.00%)
At close: 4:00 PM EDT
C$0.02
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.01 - C$0.03
Previous CloseN/A
Volume48.00K
Average Volume (3M)5.76K
Market Cap
C$7.43M
Enterprise ValueC$5.08M
Total Cash (Recent Filing)C$102.83K
Total Debt (Recent Filing)C$227.48K
Price to Earnings (P/E)―
Beta-2.69
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding495,090,100
10 Day Avg. Volume100
30 Day Avg. Volume5,759
Financial Highlights & Ratios
PEG Ratio-0.14
Price to Book (P/B)14.73
Price to Sales (P/S)15.15
P/FCF Ratio-3.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low LeverageA very low debt-to-equity (~0.02) materially reduces refinancing and interest risk for a cash-burning specialty drug maker. This capital structure gives management flexibility to raise capital on better terms, preserves liquidity for operations and R&D, and lowers near-term insolvency risk while pursuing clinical or commercial milestones.
Improving Gross MarginsA positive gross margin (~32%) and clear improvement from prior years indicate product-level economics have turned favorable. Sustained gross margins provide a foundation for operating leverage as revenue stabilizes, enabling profitability if SG&A and R&D are controlled and sales scale over the coming quarters.
Lean Operating BaseA small workforce (51 employees) suggests lower fixed payroll and SG&A overhead, allowing management to allocate scarce cash toward core R&D or regulatory steps. For a specialty pharma with ongoing cash burn, a lean headcount extends runway and improves operational flexibility to pivot programs with limited incremental cost.
Bears Say
Sharp Revenue DeclineA severe and volatile top-line collapse undermines the company's ability to scale or generate sustainable margins. With revenues down materially, funding for trials, commercialization, or fixed costs becomes difficult, increasing dependence on external financing and reducing the likelihood of consistent growth in the medium term.
Negative Operating Cash FlowOngoing negative operating and free cash flow means the business consumes cash to fund operations. Even with some improvement versus the prior year, persistent outflows force reliance on equity or debt raises, which can dilute existing holders, constrain strategic spending, and impair the company's ability to execute long-term development plans.
Equity Erosion & Negative ROEMaterial declines in shareholders' equity and persistently negative ROE reflect cumulative losses and weakening book value. This erosive trend limits borrowing capacity, reduces strategic optionality, and signals ongoing value destruction that makes it harder to attract non-dilutive capital or long-term strategic partners.
Blueberries Medical News
BBM FAQ
What was Blueberries Medical Corp’s price range in the past 12 months?
Blueberries Medical Corp lowest stock price was C$0.01 and its highest was C$0.03 in the past 12 months.
What is Blueberries Medical Corp’s market cap?
Blueberries Medical Corp’s market cap is C$7.43M.
When is Blueberries Medical Corp’s upcoming earnings report date?
Blueberries Medical Corp’s upcoming earnings report date is Sep 02, 2026 which is in 33 days.
How were Blueberries Medical Corp’s earnings last quarter?
Currently, no data Available
Is Blueberries Medical Corp overvalued?
According to Wall Street analysts Blueberries Medical Corp’s price is currently Overvalued.
Does Blueberries Medical Corp pay dividends?
Blueberries Medical Corp does not currently pay dividends.
What is Blueberries Medical Corp’s EPS estimate?
Blueberries Medical Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Blueberries Medical Corp have?
Blueberries Medical Corp has 495,090,100 shares outstanding.
What happened to Blueberries Medical Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Blueberries Medical Corp?
Currently, no hedge funds are holding shares in TSE:BBM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Blueberries Medical Corp
Headquartered in Bogotá, Colombia, Blueberries Medical Corp. operates within the medicinal cannabis industry. The company's activities encompass the entire process, from cultivating and developing to producing and supplying medical-grade cannabis and its associated products across Colombia. Their offerings notably include medicinal cannabis oil extracts and other complementary items.